Mir125a (microRNA 125a) - Rat Genome Database

Send us a Message
Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   
Search RGD Grant Resources Citing RGD About Us Contact Us
Genes Variants Community Projects QTLs Strains Markers Genome Information Ontologies Cell Lines References Download Submit Data
OntoMate (Literature Search) JBrowse (Genome Browser) Synteny Browser (VCMap) Variant Visualizer Multi-Ontology Enrichment (MOET) Gene-Ortholog Location Finder (GOLF) InterViewer (Protein-Protein Interactions) PhenoMiner (Quatitative Phenotypes) Gene Annotator OLGA (Gene List Generator) AllianceMine GViewer (Genome Viewer)
Aging & Age-Related Disease Cancer & Neoplastic Disease Cardiovascular Disease Coronavirus Disease Developmental Disease Diabetes Hematologic Disease Immune & Inflammatory Disease Infectious Disease Liver Disease Neurological Disease Obesity & Metabolic Syndrome Renal Disease Respiratory Disease Sensory Organ Disease
Find Models Genetic Models Autism Models Rat PhenoMiner (Quantitative Phenotypes) Chinchilla PhenoMiner Expected Ranges (Quantitative Phenotype) PhenoMiner Term Comparison Hybrid Rat Diversity Panel Phenotypes Phenotypes in Other Animal Models Animal Husbandry Strain Medical Records Phylogenetics Strain Availability Calendar Rats 101 Submissions Photo Archive
Pathways
Rat Community Forum Directory of Rat Laboratories Video Tutorials News RGD Publications RGD Presentations Archive Nomenclature Guidelines Resource Links Laboratory Resources Employment Resources
Advanced Search (OLGA)
Gene: Mir125a (microRNA 125a) Rattus norvegicus
Analyze
Symbol: Mir125a
Name: microRNA 125a
RGD ID: 2325387
Description: Predicted to enable mRNA 3'-UTR binding activity and mRNA base-pairing translational repressor activity. Involved in several processes, including regulation of cytokine production; regulation of vascular associated smooth muscle cell migration; and regulation of vascular associated smooth muscle cell proliferation. Predicted to be located in extracellular exosome and synapse. Used to study epilepsy and pulmonary hypertension. Biomarker of lupus nephritis and trigeminal neuralgia. Orthologous to human MIR125A (microRNA 125a); INTERACTS WITH 2,5-hexanedione; 2-methoxyethanol; amphetamine.
Type: ncrna (Ensembl: miRNA)
RefSeq Status: PROVISIONAL
Previously known as: microRNA mir-125a; rno-mir-125a
RGD Orthologs
Human
Mouse
Dog
Pig
Alliance Orthologs
More Info more info ...
Latest Assembly: mRatBN7.2 - mRatBN7.2 Assembly
Position:
Rat AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
GRCr8167,350,675 - 67,350,759 (+)NCBIGRCr8
mRatBN7.2158,677,626 - 58,677,710 (+)NCBImRatBN7.2mRatBN7.2
mRatBN7.2 Ensembl158,677,626 - 58,677,710 (+)EnsemblmRatBN7.2 Ensembl
UTH_Rnor_SHR_Utx163,502,214 - 63,502,298 (+)NCBIRnor_SHRUTH_Rnor_SHR_Utx
UTH_Rnor_SHRSP_BbbUtx_1.0172,194,878 - 72,194,962 (+)NCBIRnor_SHRSPUTH_Rnor_SHRSP_BbbUtx_1.0
UTH_Rnor_WKY_Bbb_1.0165,412,260 - 65,412,344 (+)NCBIRnor_WKYUTH_Rnor_WKY_Bbb_1.0
Rnor_6.0159,704,827 - 59,704,911 (+)NCBIRnor6.0Rnor_6.0rn6Rnor6.0
Rnor_6.0 Ensembl159,704,827 - 59,704,911 (+)EnsemblRnor6.0rn6Rnor6.0
Rnor_5.0160,624,485 - 60,624,569 (+)NCBIRnor5.0Rnor_5.0rn5Rnor5.0
Celera154,858,584 - 54,858,668 (+)NCBICelera
Cytogenetic Map1q12NCBI
JBrowse: View Region in Genome Browser (JBrowse)
Model


Gene Ontology Annotations     Click to see Annotation Detail View

Biological Process
BMP signaling pathway  (ISO)
cellular response to cortisone stimulus  (IEP)
cellular response to estrogen stimulus  (ISO)
cellular response to glucose stimulus  (IEP)
cellular response to interleukin-6  (IEP)
cellular response to leukemia inhibitory factor  (ISO)
cellular response to lipopolysaccharide  (ISO)
cellular response to platelet-derived growth factor stimulus  (IEP)
cellular response to transforming growth factor beta stimulus  (IEP)
L-ascorbic acid metabolic process  (IDA)
long-term synaptic potentiation  (ISO)
miRNA-mediated gene silencing by inhibition of translation  (ISO)
miRNA-mediated gene silencing by mRNA destabilization  (ISO)
miRNA-mediated post-transcriptional gene silencing  (ISO)
negative regulation of angiogenesis  (ISO)
negative regulation of gene expression  (ISO)
negative regulation of glomerular mesangial cell proliferation  (ISO)
negative regulation of interleukin-16 production  (ISO)
negative regulation of interleukin-17 production  (IMP)
negative regulation of interleukin-6 production  (IDA)
negative regulation of interleukin-6-mediated signaling pathway  (ISO)
negative regulation of leukocyte adhesion to vascular endothelial cell  (ISO)
negative regulation of osteoblast differentiation  (IMP)
negative regulation of receptor signaling pathway via STAT  (ISO)
negative regulation of stem cell differentiation  (ISO)
negative regulation of transforming growth factor beta production  (IDA)
negative regulation of vascular associated smooth muscle cell migration  (IDA)
negative regulation of vascular associated smooth muscle cell proliferation  (IDA)
negative regulation of vascular endothelial growth factor production  (ISO)
neuron fate specification  (ISO)
ossification  (ISO)
positive regulation of cellular process  (IMP)
positive regulation of endothelial cell apoptotic process  (ISO)
positive regulation of fat cell differentiation  (IMP)
positive regulation of gene expression  (ISO)
positive regulation of sprouting angiogenesis  (ISO)
positive regulation of vascular associated smooth muscle cell apoptotic process  (IDA)
positive regulation of vascular associated smooth muscle cell migration  (IMP)
positive regulation of vascular associated smooth muscle cell proliferation  (IMP)
regulation of cytokine production involved in inflammatory response  (IDA)
regulation of erythrocyte differentiation  (ISO)
regulation of progesterone biosynthetic process  (IDA)
stem cell differentiation  (ISO)

Cellular Component

Molecular Function

References

References - curated
# Reference Title Reference Citation
1. Epigenetic silenced miR-125a-5p could be self-activated through targeting Suv39H1 in gastric cancer. Cai M, etal., J Cell Mol Med. 2018 Oct;22(10):4721-4731. doi: 10.1111/jcmm.13716. Epub 2018 Aug 17.
2. MiR-125a-5p ameliorates monocrotaline-induced pulmonary arterial hypertension by targeting the TGF-β1 and IL-6/STAT3 signaling pathways. Cai Z, etal., Exp Mol Med. 2018 Apr 27;50(4):45. doi: 10.1038/s12276-018-0068-3.
3. Correlation Between the Hepatic Expression of Human MicroRNA hsa-miR-125a-5p and the Progression of Fibrosis in Patients With Overt and Occult HBV Infection. Coppola N, etal., Front Immunol. 2018 Jun 13;9:1334. doi: 10.3389/fimmu.2018.01334. eCollection 2018.
4. Decreased microRNA-125a-3p contributes to upregulation of p38 MAPK in rat trigeminal ganglions with orofacial inflammatory pain. Dong Y, etal., PLoS One. 2014 Nov 7;9(11):e111594. doi: 10.1371/journal.pone.0111594. eCollection 2014.
5. Down-regulation of miR-125a-3p in human gastric cancer and its clinicopathological significance. Hashiguchi Y, etal., Int J Oncol. 2012 May;40(5):1477-82. doi: 10.3892/ijo.2012.1363. Epub 2012 Feb 9.
6. MicroRNAs 125a and 455 repress lipoprotein-supported steroidogenesis by targeting scavenger receptor class B type I in steroidogenic cells. Hu Z, etal., Mol Cell Biol. 2012 Dec;32(24):5035-45. doi: 10.1128/MCB.01002-12. Epub 2012 Oct 8.
7. MiR-125a-5p Alleviates Dysfunction and Inflammation of Pentylenetetrazol- induced Epilepsy Through Targeting Calmodulin-dependent Protein Kinase IV (CAMK4). Liu Q, etal., Curr Neurovasc Res. 2019;16(4):365-372. doi: 10.2174/1567202616666190906125444.
8. Dysregulation of microRNA-125a contributes to obesity-associated insulin resistance and dysregulates lipid metabolism in mice. Liu R, etal., Biochim Biophys Acta Mol Cell Biol Lipids. 2020 May;1865(5):158640. doi: 10.1016/j.bbalip.2020.158640. Epub 2020 Jan 25.
9. Data Import for Chemical-Gene Interactions RGD automated import pipeline for gene-chemical interactions
10. Long non-coding RNA TCONS_00041960 enhances osteogenesis and inhibits adipogenesis of rat bone marrow mesenchymal stem cell by targeting miR-204-5p and miR-125a-3p. Shang G, etal., J Cell Physiol. 2018 Aug;233(8):6041-6051. doi: 10.1002/jcp.26424. Epub 2018 Feb 28.
11. SVCT2, a potential therapeutic target, protects against oxidative stress during ethanol-induced neurotoxicity via JNK/p38 MAPKs, NF-κB and miRNA125a-5p. Tian H, etal., Free Radic Biol Med. 2016 Jul;96:362-73. doi: 10.1016/j.freeradbiomed.2016.03.039. Epub 2016 Apr 13.
12. Astemizole promotes the anti-tumor effect of vitamin D through inhibiting miR-125a-5p-meidated regulation of VDR in HCC. Xu J, etal., Biomed Pharmacother. 2018 Nov;107:1682-1691. doi: 10.1016/j.biopha.2018.08.153. Epub 2018 Sep 8.
13. MicroRNA‑125a‑mediated regulation of the mevalonate signaling pathway contributes to high glucose‑induced proliferation and migration of vascular smooth muscle cells. Ye D, etal., Mol Med Rep. 2020 Apr 16. doi: 10.3892/mmr.2020.11077.
14. miR-125a-3p decreases levels of interlukin-17 and suppresses renal fibrosis via down-regulating TGF-β1 in systemic lupus erythematosus mediated Lupus nephritic mice. Zhang Y, etal., Am J Transl Res. 2019 Mar 15;11(3):1843-1853. eCollection 2019.
15. Interfering histone deacetylase 4 inhibits the proliferation of vascular smooth muscle cells via regulating MEG3/miR-125a-5p/IRF1. Zheng X, etal., Cell Adh Migr. 2019 Dec;13(1):41-49. doi: 10.1080/19336918.2018.1506653. Epub 2018 Aug 29.
Additional References at PubMed
PMID:15345052   PMID:16381832   PMID:16766679   PMID:17604727   PMID:18320040   PMID:18762567   PMID:18791161   PMID:19621438   PMID:19898466   PMID:20403161   PMID:20660734   PMID:22418008  
PMID:22751012   PMID:22897173   PMID:23104698   PMID:25751060   PMID:25858512   PMID:28502794   PMID:28593577   PMID:29039453   PMID:31696327   PMID:32239390   PMID:33284463   PMID:34284540  
PMID:35955794   PMID:36555116  


Genomics

Comparative Map Data
Mir125a
(Rattus norvegicus - Norway rat)
Rat AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
GRCr8167,350,675 - 67,350,759 (+)NCBIGRCr8
mRatBN7.2158,677,626 - 58,677,710 (+)NCBImRatBN7.2mRatBN7.2
mRatBN7.2 Ensembl158,677,626 - 58,677,710 (+)EnsemblmRatBN7.2 Ensembl
UTH_Rnor_SHR_Utx163,502,214 - 63,502,298 (+)NCBIRnor_SHRUTH_Rnor_SHR_Utx
UTH_Rnor_SHRSP_BbbUtx_1.0172,194,878 - 72,194,962 (+)NCBIRnor_SHRSPUTH_Rnor_SHRSP_BbbUtx_1.0
UTH_Rnor_WKY_Bbb_1.0165,412,260 - 65,412,344 (+)NCBIRnor_WKYUTH_Rnor_WKY_Bbb_1.0
Rnor_6.0159,704,827 - 59,704,911 (+)NCBIRnor6.0Rnor_6.0rn6Rnor6.0
Rnor_6.0 Ensembl159,704,827 - 59,704,911 (+)EnsemblRnor6.0rn6Rnor6.0
Rnor_5.0160,624,485 - 60,624,569 (+)NCBIRnor5.0Rnor_5.0rn5Rnor5.0
Celera154,858,584 - 54,858,668 (+)NCBICelera
Cytogenetic Map1q12NCBI
MIR125A
(Homo sapiens - human)
Human AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
GRCh381951,693,254 - 51,693,339 (+)NCBIGRCh38GRCh38hg38GRCh38
GRCh38.p14 Ensembl1951,693,254 - 51,693,339 (+)EnsemblGRCh38hg38GRCh38
GRCh371952,196,507 - 52,196,592 (+)NCBIGRCh37GRCh37hg19GRCh37
Build 361956,888,318 - 56,888,403 (+)NCBINCBI36Build 36hg18NCBI36
Celera1949,246,042 - 49,246,127 (+)NCBICelera
Cytogenetic Map19q13.41NCBI
HuRef1948,527,448 - 48,527,533 (+)NCBIHuRef
CHM1_11952,198,304 - 52,198,389 (+)NCBICHM1_1
T2T-CHM13v2.01954,780,417 - 54,780,502 (+)NCBIT2T-CHM13v2.0
Mir125a
(Mus musculus - house mouse)
Mouse AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
GRCm391718,051,074 - 18,051,141 (+)NCBIGRCm39GRCm39mm39
GRCm39 Ensembl1718,051,074 - 18,051,141 (+)EnsemblGRCm39 Ensembl
GRCm381717,830,812 - 17,830,879 (+)NCBIGRCm38GRCm38mm10GRCm38
GRCm38.p6 Ensembl1717,830,812 - 17,830,879 (+)EnsemblGRCm38mm10GRCm38
MGSCv371717,967,776 - 17,967,843 (+)NCBIGRCm37MGSCv37mm9NCBIm37
Celera1718,771,463 - 18,771,530 (+)NCBICelera
Cytogenetic Map17A3.2NCBI
cM Map1710.5NCBI
MIR125A
(Canis lupus familiaris - dog)
Dog AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
CanFam3.11105,400,273 - 105,400,332 (-)NCBICanFam3.1CanFam3.1canFam3CanFam3.1
CanFam3.1 Ensembl1105,400,270 - 105,400,337 (-)EnsemblCanFam3.1canFam3CanFam3.1
Dog10K_Boxer_Tasha1104,973,786 - 104,973,845 (-)NCBIDog10K_Boxer_Tasha
ROS_Cfam_1.01105,910,190 - 105,910,249 (-)NCBIROS_Cfam_1.0
UMICH_Zoey_3.11105,582,422 - 105,582,481 (-)NCBIUMICH_Zoey_3.1
UNSW_CanFamBas_1.01105,223,538 - 105,223,597 (-)NCBIUNSW_CanFamBas_1.0
UU_Cfam_GSD_1.01106,018,313 - 106,018,372 (-)NCBIUU_Cfam_GSD_1.0
MIR125A
(Sus scrofa - pig)
Pig AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
Sscrofa11.1 Ensembl658,331,566 - 58,331,645 (-)EnsemblSscrofa11.1susScr11Sscrofa11.1
Sscrofa11.1658,331,566 - 58,331,645 (-)NCBISscrofa11.1Sscrofa11.1susScr11Sscrofa11.1
Sscrofa10.2651,858,852 - 51,858,931 (+)NCBISscrofa10.2Sscrofa10.2susScr3

miRNA Target Status

Confirmed Targets
Gene TargetMature miRNAMethod NameResult TypeData TypeSupport TypePMID
Mmp9rno-miR-125a-5pMirtarbaseexternal_infoMicroarrayFunctional MTI (Weak)18258830
Scarb1rno-miR-125a-5pMirtarbaseexternal_infoLuciferase reporter assayFunctional MTI23045399
Scarb1rno-miR-125a-3pMirtarbaseexternal_infoLuciferase reporter assayFunctional MTI23045399

Predicted Targets
Summary Value
Count of predictions:13987
Count of gene targets:7483
Count of transcripts:8082
Interacting mature miRNAs:rno-miR-125a-3p, rno-miR-125a-5p
Prediction methods:Microtar, Miranda, Pita, Pita,Targetscan, Rnahybrid, Targetscan
Result types:miRGate_prediction

The detailed report is available here: Full Report CSV TAB Printer

miRNA Target Status data imported from miRGate (http://mirgate.bioinfo.cnio.es/).
For more information about miRGate, see PMID:25858286 or access the full paper here.


QTLs in Region (mRatBN7.2)
The following QTLs overlap with this region.    Full Report CSV TAB Printer Gviewer
RGD IDSymbolNameLODP ValueTraitSub TraitChrStartStopSpecies
1331732Srn4Serum renin concentration QTL 44.467renin activity (VT:0005581)plasma renin activity level (CMO:0000116)13523959878430678Rat
2313059Bss55Bone structure and strength QTL 553.20.0001tibia size trait (VT:0100001)tibia midshaft cross-sectional area (CMO:0001717)143284731118944897Rat
631688Hcas2Hepatocarcinoma susceptibility QTL 230.0001liver integrity trait (VT:0010547)liver tumorous lesion number (CMO:0001068)15925874115540829Rat
1578649Bmd8Bone mineral density QTL 84.9femur mineral mass (VT:0010011)trabecular volumetric bone mineral density (CMO:0001729)14939317294393172Rat
1358359Sradr1Stress Responsive Adrenal Weight QTL 14.74adrenal gland mass (VT:0010420)both adrenal glands wet weight (CMO:0000164)130882023123479925Rat
634314Niddm44Non-insulin dependent diabetes mellitus QTL 44blood glucose amount (VT:0000188)blood glucose level (CMO:0000046)149393289199050459Rat
4889929Bss87Bone structure and strength QTL 876.7tibia area (VT:1000281)tibia-fibula cortical bone endosteal cross-sectional area (CMO:0001722)15389511782174945Rat
1331792Rf29Renal function QTL 294.589urine potassium amount (VT:0010539)urine potassium level (CMO:0000128)13523959878430678Rat
2313062Bmd73Bone mineral density QTL 733.90.0001tibia mineral mass (VT:1000283)compact volumetric bone mineral density (CMO:0001730)11148131282174945Rat
8552900Pigfal1Plasma insulin-like growth factor 1 level QTL 17.4blood insulin-like growth factor amount (VT:0010479)plasma insulin-like growth factor 1 level (CMO:0001299)13483685879836858Rat
1578654Bss10Bone structure and strength QTL 104femur morphology trait (VT:0000559)femoral neck cortical cross-sectional area (CMO:0001702)149393172159356837Rat
1554320Bmd1Bone mineral density QTL 112.20.0001femur mineral mass (VT:0010011)volumetric bone mineral density (CMO:0001553)150910886060548Rat
1354643Foco2Food consumption QTL 27.170.0001eating behavior trait (VT:0001431)food intake rate (CMO:0000427)13344984878449848Rat
2302059Pia36Pristane induced arthritis QTL 363.80.001blood immunoglobulin amount (VT:0002460)serum immunoglobulin G1 level (CMO:0002115)14333300288333002Rat
2313065Bss67Bone structure and strength QTL 673.10.0001tibia area (VT:1000281)tibia total energy absorbed before break (CMO:0001736)11148131282174945Rat
1357400Bw62Body weight QTL624.05inguinal fat pad mass (VT:0010424)inguinal fat pad weight to body weight ratio (CMO:0001253)12234064767340647Rat
2313069Bss68Bone structure and strength QTL 682.90.0001tibia size trait (VT:0100001)tibia total energy absorbed before break (CMO:0001736)11148131282174945Rat
631495Bp96Blood pressure QTL 964.52arterial blood pressure trait (VT:2000000)systolic blood pressure (CMO:0000004)122340647102268831Rat
2313075Bss66Bone structure and strength QTL 663.40.0001tibia length (VT:0004357)tibia length (CMO:0000450)11148131282174945Rat
70225Bp58Blood pressure QTL 583.3arterial blood pressure trait (VT:2000000)systolic blood pressure (CMO:0000004)132356093162846471Rat
2298545Neuinf8Neuroinflammation QTL 84.6nervous system integrity trait (VT:0010566)spinal cord beta-2 microglobulin mRNA level (CMO:0002125)157336763151090257Rat
2313072Bss53Bone structure and strength QTL 534.30.0001tibia length (VT:0004357)tibia length (CMO:0000450)143284731118944897Rat
1300167Hrtrt2Heart rate QTL 24.35heart pumping trait (VT:2000009)heart rate (CMO:0000002)11148131275088344Rat
10059597Bp377Blood pressure QTL 3773.420.025arterial blood pressure trait (VT:2000000)systolic blood pressure (CMO:0000004)132737458199368955Rat
2313078Bss54Bone structure and strength QTL 543.50.0001tibia area (VT:1000281)tibia midshaft cross-sectional area (CMO:0001717)143284731118944897Rat
2313077Bss69Bone structure and strength QTL 693.50.0001tibia strength trait (VT:1000284)bone polar moment of inertia (CMO:0001558)11148131282174945Rat
1331778Rf28Renal function QTL 284.66urine potassium amount (VT:0010539)urine potassium excretion rate (CMO:0000761)14580314078430678Rat
2313402Anxrr24Anxiety related response QTL 24aggression-related behavior trait (VT:0015014)tameness/aggressiveness composite score (CMO:0002136)148963584144267916Rat
1331785Rf27Renal function QTL 274.643urine sodium amount (VT:0006274)urine sodium level (CMO:0000129)12887978078430678Rat
61342Bp27Blood pressure QTL 273.40.0006arterial blood pressure trait (VT:2000000)systolic blood pressure (CMO:0000004)15673266898773277Rat
1300172Bp172Blood pressure QTL 1723.56arterial blood pressure trait (VT:2000000)diastolic blood pressure (CMO:0000005)13273727390665040Rat
4889962Bss94Bone structure and strength QTL 943.8tibia area (VT:1000281)tibia-fibula cortical bone endosteal cross-sectional area (CMO:0001722)14936146582174945Rat
724520Bp145Blood pressure QTL 1452.10.0024arterial blood pressure trait (VT:2000000)systolic blood pressure (CMO:0000004)12078482865784828Rat
2313094Bss58Bone structure and strength QTL 583.70.0001tibia strength trait (VT:1000284)tibia total energy absorbed before break (CMO:0001736)143284731118944897Rat
6903308Scl36Serum cholesterol QTL 3620.0125blood cholesterol amount (VT:0000180)plasma total cholesterol level (CMO:0000585)15386304190532583Rat
2313092Bmd72Bone mineral density QTL 722.50.0001tibia mineral mass (VT:1000283)total volumetric bone mineral density (CMO:0001728)11148131282174945Rat
2300164Bmd44Bone mineral density QTL 445.40.0001lumbar vertebra mineral mass (VT:0010511)volumetric bone mineral density (CMO:0001553)156949932101949932Rat
2313099Bss56Bone structure and strength QTL 562.40.0001tibia size trait (VT:0100001)tibia midshaft endosteal cross-sectional area (CMO:0001716)143284731118944897Rat
2313098Bmd70Bone mineral density QTL 703.60.0001tibia mineral mass (VT:1000283)compact volumetric bone mineral density (CMO:0001730)143284731118944897Rat
2313097Bss70Bone structure and strength QTL 703.50.0001tibia strength trait (VT:1000284)tibia total energy absorbed before break (CMO:0001736)11148131282174945Rat
9589820Insglur3Insulin/glucose ratio QTL 310.750.001blood insulin amount (VT:0001560)calculated plasma insulin level (CMO:0002170)13483685879836858Rat
738020Pia8Pristane induced arthritis QTL 84.7joint integrity trait (VT:0010548)joint inflammation composite score (CMO:0000919)1165833076Rat
1354599Bw29Body weight QTL 293.460.001body mass (VT:0001259)body weight (CMO:0000012)13344984878449848Rat
4889919Bss86Bone structure and strength QTL 864.1tibia area (VT:1000281)tibia midshaft total cross-sectional area (CMO:0001715)15389511782174945Rat
8552948Pigfal11Plasma insulin-like growth factor 1 level QTL 114.7blood insulin-like growth factor amount (VT:0010479)plasma insulin-like growth factor 1 level (CMO:0001299)13483685879836858Rat
2313051Bss57Bone structure and strength QTL 573.70.0001tibia strength trait (VT:1000284)bone polar moment of inertia (CMO:0001558)143284731118944897Rat


Expression

RNA-SEQ Expression

alimentary part of gastrointestinal system
appendage
circulatory system
ectoderm
endocrine system
endoderm
exocrine system
hemolymphoid system
hepatobiliary system
mesenchyme
mesoderm
nervous system
renal system
reproductive system
respiratory system
2 4 20 65 16 15 2 10 2 68 39 56 21 40 13

Sequence

Nucleotide Sequences
RefSeq Transcripts NR_031868 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
GenBank Nucleotide JAXUCZ010000001 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles

Ensembl Acc Id: ENSRNOT00000053695
Type: CODING
Position:
Rat AssemblyChrPosition (strand)Source
mRatBN7.2 Ensembl158,677,626 - 58,677,710 (+)Ensembl
Rnor_6.0 Ensembl159,704,827 - 59,704,911 (+)Ensembl
RefSeq Acc Id: NR_031868
RefSeq Status: PROVISIONAL
Type: NON-CODING
Position:
Rat AssemblyChrPosition (strand)Source
GRCr8167,350,675 - 67,350,759 (+)NCBI
mRatBN7.2158,677,626 - 58,677,710 (+)NCBI
Rnor_6.0159,704,827 - 59,704,911 (+)NCBI
Rnor_5.0160,624,485 - 60,624,569 (+)NCBI
Celera154,858,584 - 54,858,668 (+)NCBI
Sequence:
Transcriptome

eQTL   View at Phenogen
WGCNA   View at Phenogen
Tissue/Strain Expression   View at Phenogen


Additional Information

Database Acc Id Source(s)
AGR Gene RGD:2325387 AgrOrtholog
BioCyc Gene G2FUF-61256 BioCyc
Ensembl Genes ENSRNOG00000035572 Ensembl
miRBase MI0000895 ENTREZGENE
NCBI Gene 100314236 ENTREZGENE
PhenoGen Mir125a PhenoGen
RatGTEx ENSRNOG00000035572 RatGTEx
RNAcentral URS00001F0C23 RNACentral
  URS00005A4DCF RNACentral
  URS000075C84F RNACentral


Nomenclature History
Date Current Symbol Current Name Previous Symbol Previous Name Description Reference Status
2013-08-14 Mir125a  microRNA 125a  Mir125a  microRNA mir-125a  Nomenclature updated to reflect human and mouse nomenclature 1299863 APPROVED
2010-06-02 Mir125a  microRNA mir-125a      Symbol and Name status set to provisional 70820 PROVISIONAL